MOGROSIDE V

Details

Stereochemistry	ABSOLUTE
Molecular Formula	C60H102O29
Molecular Weight	1287.4345
Optical Activity	UNSPECIFIED
Defined Stereocenters	35 / 35
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

[H][C@@]1(CC[C@@]2(C)[C@]3([H])CC=C4[C@@]([H])(CC[C@H](O[C@]5([H])O[C@H](CO[C@@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)[C@@H](O)[C@H](O)[C@H]5O)C4(C)C)[C@]3(C)[C@H](O)C[C@]12C)[C@H](C)CC[C@@H](O[C@@H]7O[C@H](CO[C@@H]8O[C@H](CO)[C@@H](O)[C@H](O)[C@H]8O)[C@@H](O)[C@H](O)[C@H]7O[C@]9([H])O[C@H](CO)[C@@H](O)[C@H](O)[C@H]9O)C(C)(C)O

InChI

InChIKey=GHBNZZJYBXQAHG-KUVSNLSMSA-N

InChI=1S/C60H102O29/c1-23(9-13-35(57(4,5)79)88-55-50(89-54-49(78)43(72)38(67)29(20-63)84-54)45(74)40(69)31(86-55)22-81-52-47(76)42(71)37(66)28(19-62)83-52)24-15-16-58(6)32-12-10-25-26(60(32,8)33(64)17-59(24,58)7)11-14-34(56(25,2)3)87-53-48(77)44(73)39(68)30(85-53)21-80-51-46(75)41(70)36(65)27(18-61)82-51/h10,23-24,26-55,61-79H,9,11-22H2,1-8H3/t23-,24-,26-,27-,28-,29-,30-,31-,32+,33-,34+,35-,36-,37-,38-,39-,40-,41+,42+,43+,44+,45+,46-,47-,48-,49-,50-,51-,52-,53+,54+,55+,58+,59-,60+/m1/s1

HIDE SMILES / InChI

Approval Year

Targets

Primary Target	Pharmacology	Condition	Potency
inflammatory response 47 Target ID: GO:0006954 Sources: https://www.ncbi.nlm.nih.gov/pubmed/24621273 \| https://www.ncbi.nlm.nih.gov/pubmed/30877761	Inhibitor 8297
angiogenesis 17 Target ID: GO:0001525 Sources: https://www.ncbi.nlm.nih.gov/pubmed/27065453	Inhibitor 8297
reactive oxygen species metabolic process 68 Target ID: GO:0072593 Sources: https://www.ncbi.nlm.nih.gov/pubmed/30060618	Modulator 828

PubMed

Title	Date	PubMed
Analysis of Mogroside V in Siraitia grosvenorii with micelle-mediated cloud-point extraction.	2013 Jul-Aug	23349010
The biosynthetic pathway of the nonsugar, high-intensity sweetener mogroside V from Siraitia grosvenorii.	2016 Nov 22	27821754
The metabolism of a natural product mogroside V, in healthy and type 2 diabetic rats.	2018 Mar 15	29428672
Quantitative determination of mogroside V in rat plasma by LC-MS/MS and its application to a pharmacokinetic study.	2018 May	29716867

Name

Type

Language

MOGROSIDE V

Common Name

English

MOGROSIDE V [USP-RS]

Common Name

English

.BETA.-D-GLUCOPYRANOSIDE, (3.BETA.,9.BETA.,10.ALPHA.,11.ALPHA.,24R)-3-((6-O-.BETA.-D-GLUCOPYRANOSYL-.BETA.-D-GLUCOPYRANOSYL)OXY)-11,25-DIHYDROXY-9-METHYL-19-NORLANOST-5-EN-24-YL O-.BETA.-D-GLUCOPYRANOSYL-(1->2)-O-(.BETA.-D-GLUCOPYRANOSYL-(1->6))-

Systematic Name

English

(3.BETA.,9.BETA.,10.ALPHA.,11.ALPHA.,24R)-3-((6-O-.BETA.-D-GLUCOPYRANOSYL-.BETA.-D-GLUCOPYRANOSYL)OXY)-11,25-DIHYDROXY-9-METHYL-19-NORLANOST-5-EN-24-YL O-.BETA.-D-GLUCOPYRANOSYL-(1->2)-O-(.BETA.-D-GLUCOPYRANOSYL-(1->6))-.BETA.-D-GLUCOPYRANOSIDE

Systematic Name

English

MOGROL-3-O-(.BETA.-D-GLUCOPYRANOSYL (1-6)-.BETA.-D-GLUCOPYRANOSIDE)-24-O-((.BETA.-D-GLUCOPYRANOSYL (1-2))-(.BETA.-D-GLUCOPYRANOSYL(1-6))-.BETA.-D-GLUCOPYRANOSIDE)

Common Name

English

Code System Code Type Description

FDA UNII

ZFF6Z51TUR

Created by admin on Sat Dec 16 11:00:56 GMT 2023 , Edited by admin on Sat Dec 16 11:00:56 GMT 2023

PRIMARY

PUBCHEM

24721270

Created by admin on Sat Dec 16 11:00:56 GMT 2023 , Edited by admin on Sat Dec 16 11:00:56 GMT 2023

PRIMARY

RS_ITEM_NUM

1445448

Created by admin on Sat Dec 16 11:00:56 GMT 2023 , Edited by admin on Sat Dec 16 11:00:56 GMT 2023

PRIMARY

CAS

88901-36-4

Created by admin on Sat Dec 16 11:00:56 GMT 2023 , Edited by admin on Sat Dec 16 11:00:56 GMT 2023

PRIMARY

SUBSTANCE RECORD


					ZFF6Z51TUR

MOGROSIDE V